Home - Blaise Group

Encompassing all Executive through Board Positions in Life Sciences

Director of the Board

Yes

Chief Executive Officer

Yes

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.

Chairman of the Board

Yes

Chief Financial Officer

Formerly Aastrom Biosciences

Yes

Chief Operating Officer

Yes

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company

Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.

Yes

In The News

Engrafting Bacteria for Therapeutic Advantage in Kidney-Related Diseases

Proof of concept for the Genetically Engineered Microbial Medicines (GEMM) platform came in a recent first-in-human, Phase I trial.

https://www.biospace.com/article/engrafting-bacteria-for-therapeutic-advantage-in-kidney-related-diseases-/

METiS Launches to Take Drug Development a Quantum Leap Ahead

The Cambridge, Massachusetts-based company has developed an artificial intelligence platform designed to optimize pharmaceutical formulation processes.

https://www.biospace.com/article/metis-launches-to-take-drug-development-a-quantum-leap-ahead-/

What Omicron Could Teach Us About Predicting Future COVID-19 Variants

Despite having 37 new mutations in the viral spike protein, there does not appear to be any deaths associated with Omicron, although it’s spreading rapidly in South Africa.

https://www.biospace.com/article/can-omicron-help-us-predict-future-covid-19-variants-/

Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trial

Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trial fkansteiner Tue, 12/07/2021 – 16:35

https://www.fiercepharma.com/pharma/shkreli-s-former-company-vyera-settles-for-40m-daraprim-antitrust-case-but-pharma-bro-has